Atea Pharmaceuticals, Inc. (AVIR) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $315.22M | -32.2% |
| 2024 | $464.67M | -21.9% |
| 2023 | $594.97M | -10.8% |
| 2022 | $666.71M | -13.7% |
| 2021 | $772.89M | -10.5% |
| 2020 | $863.63M | +3812.6% |
| 2019 | $22.07M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $315.22M | -32.2% |
| 2024 | $464.67M | -21.9% |
| 2023 | $594.97M | -10.8% |
| 2022 | $666.71M | -13.7% |
| 2021 | $772.89M | -10.5% |
| 2020 | $863.63M | +3812.6% |
| 2019 | $22.07M | — |